416 related articles for article (PubMed ID: 19638344)
1. Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library.
Zhao L; Pan Y; Gang Y; Wang H; Jin H; Tie J; Xia L; Zhang Y; He L; Yao L; Qiao T; Li T; Liu Z; Fan D
J Biol Chem; 2009 Sep; 284(39):26273-85. PubMed ID: 19638344
[TBL] [Abstract][Full Text] [Related]
2. DJ-1 is involved in the multidrug resistance of SGC7901 gastric cancer cells through PTEN/PI3K/Akt/Nrf2 pathway.
Qiu L; Ma Z; Li X; Deng Y; Duan G; Zhao LE; Xu X; Xiao L; Liu H; Zhu Z; Chen H
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1202-1214. PubMed ID: 33079995
[TBL] [Abstract][Full Text] [Related]
3. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinoma.
Lee YK; Lin TH; Chang CF; Lo YL
PLoS One; 2013; 8(11):e82478. PubMed ID: 24303084
[TBL] [Abstract][Full Text] [Related]
5. Growth arrest-specific gene 1 is downregulated and inhibits tumor growth in gastric cancer.
Wang H; Zhou X; Zhang Y; Zhu H; Zhao L; Fan L; Wang Y; Gang Y; Wu K; Liu Z; Fan D
FEBS J; 2012 Oct; 279(19):3652-3664. PubMed ID: 22846196
[TBL] [Abstract][Full Text] [Related]
6. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
7. Shugoshin1 enhances multidrug resistance of gastric cancer cells by regulating MRP1, Bcl-2, and Bax genes.
Wang Y; Liu L; Liu X; Zhang H; Liu J; Feng B; Shang Y; Zhou L; Wu K; Nie Y; Zhang H; Fan D
Tumour Biol; 2013 Aug; 34(4):2205-14. PubMed ID: 23564482
[TBL] [Abstract][Full Text] [Related]
8. Activating transcription factor 4 confers a multidrug resistance phenotype to gastric cancer cells through transactivation of SIRT1 expression.
Zhu H; Xia L; Zhang Y; Wang H; Xu W; Hu H; Wang J; Xin J; Gang Y; Sha S; Xu B; Fan D; Nie Y; Wu K
PLoS One; 2012; 7(2):e31431. PubMed ID: 22363646
[TBL] [Abstract][Full Text] [Related]
9. [Reversal of multidrug resistance of gastric cancer cells by down-regulation of CIAPIN1 with CIAPIN1 siRNA].
Li X; Fan R; Zou X; Hong L; Gao L; Jin H; Du R; He L; Xia L; Fan D
Mol Biol (Mosk); 2008; 42(1):102-9. PubMed ID: 18389626
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma.
Zhang H; Li M; Han Y; Hong L; Gong T; Sun L; Zheng X
Dig Dis Sci; 2010 Sep; 55(9):2545-51. PubMed ID: 19960259
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of miRNA-200c on chemotherapy-resistance and cell proliferation of gastric cancer SGC7901/DDP cells.
Chen Y; Zuo J; Liu Y; Gao H; Liu W
Chin J Cancer; 2010 Dec; 29(12):1006-11. PubMed ID: 21114921
[TBL] [Abstract][Full Text] [Related]
12. Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation.
Yan LH; Wang XT; Yang J; Lian C; Kong FB; Wei WY; Luo W; Xiao Q; Xie YB
World J Gastroenterol; 2013 Jul; 19(26):4155-65. PubMed ID: 23864778
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of P-glycoprotein functionality by vandetanib may reverse cancer cell resistance to doxorubicin.
Jovelet C; Bénard J; Forestier F; Farinotti R; Bidart JM; Gil S
Eur J Pharm Sci; 2012 Aug; 46(5):484-91. PubMed ID: 22484209
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
Lin GL; Ting HJ; Tseng TC; Juang V; Lo YL
PLoS One; 2017; 12(10):e0185625. PubMed ID: 28968471
[TBL] [Abstract][Full Text] [Related]
15. Depression of MAD2 inhibits apoptosis and increases proliferation and multidrug resistance in gastric cancer cells by regulating the activation of phosphorylated survivin.
Wang L; Yin F; Du Y; Chen B; Liang S; Zhang Y; Du W; Wu K; Ding J; Fan D
Tumour Biol; 2010 Jun; 31(3):225-32. PubMed ID: 20440596
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
[TBL] [Abstract][Full Text] [Related]
17. Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone.
Li DQ; Wang ZB; Bai J; Zhao J; Wang Y; Hu K; Du YH
World J Gastroenterol; 2004 Jun; 10(12):1722-5. PubMed ID: 15188493
[TBL] [Abstract][Full Text] [Related]
18. Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells.
Lan WG; Xu DH; Xu C; Ding CL; Ning FL; Zhou YL; Ma LB; Liu CM; Han X
Oncol Rep; 2016 Jul; 36(1):263-70. PubMed ID: 27121324
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells.
Zhu CY; Lv YP; Yan DF; Gao FL
Asian Pac J Cancer Prev; 2013; 14(11):6757-60. PubMed ID: 24377601
[TBL] [Abstract][Full Text] [Related]
20. Reversal of Multidrug Resistance in an Epirubicin-Resistant Gastric Cancer Cell Subline.
Felipe AV; Oliveira J; Moraes AA; França JP; Silva TD; Forones NM
Asian Pac J Cancer Prev; 2018 May; 19(5):1237-1242. PubMed ID: 29801407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
